Advertisement

Inpharma Weekly

, Volume 1167, Issue 1, pp 19–19 | Cite as

Idarubicin preferred to daunorubicin as AML induction therapy

Newsletter Article
  • 2 Downloads

Keywords

Complete Remission Myeloid Leukaemia British Journal Anthracyclines Cytarabine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1998

Personalised recommendations